Molecular diversity through RNA editing: a balancing act

Trends in Genetics

Volumn 26, Issue 5, 2010, Pages 221-230

  Farajollahi, Sanaz ^a   Maas, Stefan ^a  

^a LEHIGH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; INOSINE; MICRORNA; RNA; TRANSCRIPTOME; PROTEIN;

ALTERNATIVE RNA SPLICING; AMINO ACID SUBSTITUTION; DEAMINATION; EUKARYOTE; EXON; GENE EXPRESSION; GENETIC DISORDER; GENETIC VARIABILITY; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION; RETROPOSON; REVIEW; RNA EDITING; RNA TRANSCRIPTION; RNA TRANSLATION; ANIMAL; GENETICS; METABOLISM; NEOPLASM; NEUROLOGIC DISEASE;

EUKARYOTA;

ADENOSINE; ANIMALS; DEAMINATION; HUMANS; NEOPLASMS; NERVOUS SYSTEM DISEASES; PROTEINS; RNA EDITING;

EID: 77951922861     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2010.02.001     Document Type: Review

References (100)

1. Gott J.M., Emeson R.B. Functions and mechanisms of RNA editing. Annu. Rev. Genet. 2000, 34:499-531.
2. Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annual Reviews in Biochemistry 2010, 79:1-29. [Epub ahead of print] PMID: 20192758.
3. Bass B.L. RNA editing by adenosine deaminases that act on RNA. Annu. Rev. Biochem. 2002, 71:817-846.
4. Gommans W.M., et al. RNA editing: a driving force for adaptive evolution?. BioEssays 2009, 31:1137-1145.
5. Gommans W.M., et al. Diversifying exon code through A-to-I RNA editing. DNA RNA Editing 2008, 3-30. Wiley & Sons Inc. H. Smith (Ed.).
6. Li J.B., et al. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 2009, 324:1210-1213.
7. Shah S.P., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813.
8. Reenan R.A. Molecular determinants and guided evolution of species-specific RNA editing. Nature 2005, 434:409-413.
9. Athanasiadis A., et al. Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol. 2004, 2:e391.
10. Blow M., et al. A survey of RNA editing in human brain. Genome Res. 2004, 14:2379-2387.
11. Kim D.D., et al. Widespread RNA editing of embedded alu elements in the human transcriptome. Genome Res. 2004, 14:1719-1725.
12. Levanon E.Y., et al. Systematic identification of abundant A-to-I editing sites in the human transcriptome. Nat. Biotechnol. 2004, 22:1001-1005.
13. Barak M., et al. Evidence for large diversity in the human transcriptome created by Alu RNA editing. Nucleic Acids Res. 2009, 37:6905-6915.
14. Lev-Maor G., et al. RNA-editing-mediated exon evolution. Genome Biol. 2007, 8:R29.
15. Borchert G.M., et al. Adenosine deamination in human transcripts generates novel microRNA binding sites. Hum. Mol. Genet. 2009, 18:4801-4807.
16. Wang Q., et al. Vigilins bind to promiscuously A-to-I-edited RNAs and are involved in the formation of heterochromatin. Curr. Biol. 2005, 15:384-391.
17. Zhang Z., Carmichael G.G. The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 2001, 106:465-475.
18. Hundley H.A., et al. C. elegans and H. sapiens mRNAs with edited 3' UTRs are present on polysomes. RNA 2008, 14:2050-2060.
19. Chen L.L., Carmichael G.G. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol. Cell 2009, 35:467-478.
20. Prasanth K.V., et al. Regulating gene expression through RNA nuclear retention. Cell 2005, 123:249-263.
21. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
22. Luciano D.J., et al. RNA editing of a miRNA precursor. RNA 2004, 10:1174-1177.
23. Pfeffer S., et al. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2:269-276.
24. Kawahara Y., et al. RNA editing of the microRNA-151 precursor blocks cleavage by the Dicer-TRBP complex. EMBO Rep. 2007, 8:763-769.
25. Yang W., et al. Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat. Struct. Mol. Biol. 2006, 13:13-21.
26. Kawahara Y., et al. Frequency and fate of microRNA editing in human brain. Nucleic Acids Res. 2008, 36:5270-5280.
27. Kawahara Y., et al. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science 2007, 315:1137-1140.
28. Liang H., Landweber L.F. Hypothesis: RNA editing of microRNA target sites in humans?. RNA 2007, 13:463-467.
29. Mightdanovych O., Beal P.A. Breaking the central dogma by RNA editing. Chem. Rev. 2006, 106:3397-3411.
30. Schwartz T., et al. Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science 1999, 284:1841-1845.
31. Maas S., Gommans W.M. Identification of a selective nuclear import signal in adenosine deaminases acting on RNA. Nucleic Acids Res. 2009, 37:5822-5829.
32. Fritz J., et al. RNA-regulated interaction of transportin-1 and exportin-5 with the double-stranded RNA-binding domain regulates nucleocytoplasmic shuttling of ADAR1. Mol. Cell Biol. 2009, 29:1487-1497.
33. Desterro J.M., et al. Dynamic association of RNA-editing enzymes with the nucleolus. J. Cell Sci. 2003, 116:1805-1818.
34. Sansam C.L., et al. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:14018-14023.
35. Rueter S.M., et al. Regulation of alternative splicing by RNA editing. Nature 1999, 399:75-80.
36. Palladino M.J., et al. dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing. Rna 2000, 6:1004-1018.
37. Valente L., Nishikura K. RNA binding-independent dimerization of adenosine deaminases acting on RNA and dominant negative effects of nonfunctional subunits on dimer functions. J. Biol. Chem. 2007, 282:16054-16061.
38. Ohta H., et al. ADBP-1 regulates an ADAR RNA-editing enzyme to antagonize RNA-interference-mediated gene silencing in Caenorhabditis elegans. Genetics 2008, 180:785-796.
39. Agranat L., et al. The editing enzyme ADAR1 and the mRNA surveillance protein hUpf1 interact in the cell nucleus. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:5028-5033.
40. Desterro J.M., et al. SUMO-1 modification alters ADAR1 editing activity. Mol. Biol. Cell 2005, 16:5115-5126.
41. Higuchi M., et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 2000, 406:78-81.
42. Reenan R.A., et al. The mle(napts) RNA helicase mutation in Drosophila results in a splicing catastrophe of the para Na+ channel transcript in a region of RNA editing. Neuron. 2000, 25:139-149.
43. Ryman K., et al. The C-terminal domain of RNA Pol II helps ensure that editing precedes splicing of the GluR-B transcript. RNA 2007, 13:1071-1078.
44. Raitskin O., et al. RNA editing activity is associated with splicing factors in lnRNP particles: The nuclear pre-mRNA processing machinery. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6571-6576.
45. Kishore S., Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 2006, 311:230-232.
46. Doe C.M., et al. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum. Mol. Genet. 2009, 18:2140-2148.
47. Vitali P., et al. ADAR2-mediated editing of RNA substrates in the nucleolus is inhibited by C/D small nucleolar RNAs. J. Cell. Biol. 2005, 169:745-753.
48. Palladino M.J., et al. A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 2000, 102:437-449.
49. Jepson J.E., Reenan R.A. Adenosine-to-inosine genetic recoding is required in the adult stage nervous system for coordinated behavior in Drosophila. J. Biol. Chem. 2009, 284:31391-31400.
50. Hartner J.C., et al. Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1. J. Biol. Chem. 2004, 279:4894-4902.
51. Wang Q., et al. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 2000, 290:1765-1768.
52. Hartner J.C., et al. ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling. Nat. Immunol. 2009, 10:109-115.
53. XuFeng R., et al. ADAR1 is required for hematopoietic progenitor cell survival via RNA editing. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17763-17768.
54. Keegan L.P., et al. Tuning of RNA editing by ADAR is required in Drosophila. EMBO J. 2005, 24:2183-2193.
55. Feng Y., et al. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol. Cell Biol. 2006, 26:480-488.
56. Singh M., et al. Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J. Biol. Chem. 2007, 282:22448-22459.
57. Tojo K., et al. Dystonia, mental deterioration, and dyschromatosis symmetrica hereditaria in a family with ADAR1 mutation. Mov. Disord. 2006, 21:1510-1513.
58. Heale B.S., et al. Editing independent effects of ADARs on the miRNA/siRNA pathways. EMBO J. 2009, 28:3145-3156.
59. Sebastiani P., et al. RNA editing genes associated with extreme old age in humans and with lifespan in C. elegans. PLoS ONE 2009, 4:e8210. PMID: 20011587.
60. Gallo A., Galardi S. A-to-I RNA editing and cancer: from pathology to basic science. RNA Biol. 2008, 5.
61. Paz N., et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 2007, 17:1586-1595.
62. Cenci C., et al. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J. Biol. Chem. 2008, 283:7251-7260.
63. Maas S., et al. Underediting of glutamate receptor GluR-B mRNA in malignant gliomas. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14687-14692.
64. Ishiuchi S., et al. Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat. Med. 2002, 8:971-978.
65. Maas S., et al. A-to-I RNA editing and human disease. RNA Biol. 2006, 3:1-9.
66. Martinez H.D., et al. RNA editing of androgen receptor gene transcripts in prostate cancer cells. J. Biol. Chem. 2008, 283:29938-29949.
67. Sotiropoulou G., et al. Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. RNA 2009, 15:1443-1461.
68. Chen C.Z., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004, 303:83-86.
69. Lee E.J., et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 2007, 120:1046-1054.
70. Brusa R., et al. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 1995, 270:1677-1680.
71. Vissel B., et al. The role of RNA editing of kainate receptors in synaptic plasticity and seizures. Neuron. 2001, 29:217-227.
72. Mattick J.S., Mehler M.F. RNA editing, DNA recoding and the evolution of human cognition. Trends Neurosci. 2008, 31:227-233.
73. Modrek B., Lee C.J. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat. Genet. 2003, 34:177-180.
74. Kawahara Y., et al. Dysregulated editing of serotonin 2C receptor mRNAs results in energy dissipation and loss of fat mass. J. Neurosci. 2008, 28:12834-12844.
75. Singh M., et al. Affect-related behaviors in mice misexpressing the RNA editing enzyme ADAR2. Physiol. Behav. 2009, 97:446-454.
76. Gardiner K., Du Y. A-to-I editing of the 5HT2C receptor and behaviour. Brief Funct. Genomic Proteomic 2006, 5:37-42.
77. Berg K.A., et al. Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications. Neuropharmacology 2008, 55:969-976.
78. Schmauss C. Regulation of serotonin 2C receptor pre-mRNA editing by serotonin. Int. Rev. Neurobiol. 2005, 63:83-100.
79. Gurevich I., et al. Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron. 2002, 34:349-356.
80. Sodhi M.S., et al. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol. Psychiatry 2001, 6:373-379.
81. Englander M.T., et al. How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J. Neurosci. 2005, 25:648-651.
82. Yang W., et al. ADAR1 RNA deaminase limits short interfering RNA efficacy in mammalian cells. J. Biol. Chem. 2005, 280:3946-3953.
83. Kawakubo K., Samuel C.E. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 2000, 258:165-172.
84. Rosenberg B.R., Papavasiliou F.N. Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection. Adv. Immunol. 2007, 94:215-244.
85. Doria M., et al. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 2009, 37:5848-5858.
86. Phuphuakrat A., et al. Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins. J. Virol. 2008, 82:10864-10872.
87. Nie Y., et al. Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. J. Virol. 2007, 81:917-923.
88. Toth A.M., et al. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J. Biol. Chem. 2009, 284:29350-29356.
89. Casey J.L. RNA editing in hepatitis delta virus. Curr. Top. Microbiol. Immunol. 2006, 307:67-89.
90. Laxminarayana D., et al. Transcript mutations of the alpha regulatory subunit of protein kinase A and up-regulation of the RNA-editing gene transcript in lupus T lymphocytes. Lancet 2002, 360:842-849.
91. Orlowski R.J., et al. Altered editing in cyclic nucleotide phosphodiesterase 8A1 gene transcripts of systemic lupus erythematosus T lymphocytes. Immunology 2008, 125(3):408-419. Epub 2008 May 6.
92. Yang J.H., et al. Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation. Immunology 2003, 109:15-23.
93. Aronoff R., et al. Neuronal toxicity in Caenorhabditis elegans from an editing site mutant in glutamate receptor channels. J. Neurosci. 2004, 24:8135-8140.
94. Batzer M.A., Deininger P.L. Alu repeats and human genomic diversity. Nat. Rev. Genet. 2002, 3:370-379.
95. Gerber A.P., Keller W. RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem. Sci. 2001, 26:376-384.
96. Macbeth M.R., et al. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 2005, 309:1534-1539.
97. Maas S., Gommans W.M. Novel exon of mammalian ADAR2 extends open reading frame. PLoS ONE 2009, 4:e4225.
98. Doe C.M., et al. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR mediated behaviour. Hum. Mol. Genet. 2009, 18(12):2140-2148. Epub 2009 Mar 20.
99. Kawahara Y., et al. Glutamate receptors: RNA editing and death of motor neurons. Nature 2004, 427:801.
100. Beghini A., et al. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum. Mol. Genet. 2000, 9:2297-2304.